Latest Morning Briefing Stories

KHN’s ‘What the Health?’: Dealing With Drug Prices

Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.

Ask KHN-PolitiFact: Is My Cloth Mask Good Enough? The 2022 Edition

With the omicron variant surging throughout the U.S., many experts warn that a single-layer cloth mask is not enough protection. Instead, they recommend an upgrade: layering wardrobe masks with surgical masks or wearing an N95 or KN95 respirator. Some places, including Los Angeles County, are already implementing stricter policies.

Supreme Court Weighs Biden’s Workplace Vaccine Requirements

The court is considering whether to let the rules go into effect as opponents fight them in lower courts. Conservative justices pressed lawyers hard about whether the administration overstepped its authority, but liberal members of the high court questioned why the government shouldn’t be expected to move forcefully when facing a severe health crisis.